As of 2026-07-15, the Relative Valuation of Charles River Laboratories International Inc (CRL) is (73.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 231.21 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is -131.6%.
The range of the Relative Valuation is (114.92) - 18.97 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.0x - 55.2x | 41.8x |
| Forward P/E multiples | 25.5x - 36.8x | 26.8x |
| Fair Price | (114.92) - 18.97 | (73.11) |
| Upside | -149.7% - -91.8% | -131.6% |
| Date | P/E |
| 2026-07-14 | -60.32 |
| 2026-07-13 | -59.94 |
| 2026-07-10 | -60.89 |
| 2026-07-09 | -60.94 |
| 2026-07-08 | -58.42 |
| 2026-07-07 | -59.66 |
| 2026-07-06 | -60.37 |
| 2026-07-02 | -60.18 |
| 2026-07-01 | -59.76 |
| 2026-06-30 | -59.16 |
| 2026-06-29 | -58.84 |
| 2026-06-26 | -56.28 |
| 2026-06-25 | -55.49 |
| 2026-06-24 | -52.72 |
| 2026-06-23 | -48.68 |
| 2026-06-22 | -47.36 |
| 2026-06-18 | -48.26 |
| 2026-06-17 | -47.57 |
| 2026-06-16 | -48.21 |
| 2026-06-15 | -49.17 |
| 2026-06-12 | -48.92 |
| 2026-06-11 | -49.06 |
| 2026-06-10 | -48.60 |
| 2026-06-09 | -49.53 |
| 2026-06-08 | -48.64 |
| 2026-06-05 | -47.31 |
| 2026-06-04 | -48.47 |
| 2026-06-03 | -46.92 |
| 2026-06-02 | -45.60 |
| 2026-06-01 | -47.50 |
| 2026-05-29 | -47.14 |
| 2026-05-28 | -47.31 |
| 2026-05-27 | -42.91 |
| 2026-05-26 | -40.89 |
| 2026-05-22 | -41.82 |
| 2026-05-21 | -41.44 |
| 2026-05-20 | -40.70 |
| 2026-05-19 | -39.76 |
| 2026-05-18 | -39.11 |
| 2026-05-15 | -39.35 |
| 2026-05-14 | -41.51 |
| 2026-05-13 | -42.48 |
| 2026-05-12 | -44.01 |
| 2026-05-11 | -43.95 |
| 2026-05-08 | -46.34 |
| 2026-05-07 | -47.40 |
| 2026-05-06 | -47.41 |
| 2026-05-05 | -48.36 |
| 2026-05-04 | -44.95 |
| 2026-05-01 | -43.25 |